Literature DB >> 15004658

Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.

W J Kruszewski1, R Rzepko, J Wojtacki, J Skokowski, A Kopacz, K Jaśkiewicz, K Drucis.   

Abstract

Some studies have shown the influence of proteases and vascular density in colorectal primary tumors on spreading and on the course of colorectal cancer. In the present study we have analyzed the relationships between overexpression of cathepsin B protein and angiogenesis intensity in resected colon tumors and their impact on prognosis. It has been investigated in a series of 90 colon cancer patients. Immunohistochemistry was used to evaluate cathepsin B overexpression in cancer cells and to visualize microvessels with antibodies against von Willebrand factor. Overexpression of cathepsin B was observed if more than 50% of cancer cells in searched field showed immunoreactivity with antibody against cathepsin B. Intensity of angiogenesis was evaluated as a mean number of microvessels from three fields with highest vessel number. In 36 cases (40%) overexpression of cathepsin B was detected. Increased angiogenesis (above median 31 vessels per 0.785 mm2) correlated positively with cathepsin B overexpression (p=0.0006). Higher vascular density associated with the presence of metastases in regional lymph nodes (p=0.01). Overexpression of cathepsin B was observed more often in group of older people (age above median 65 years; p=0.005). According to univariate analysis metastases in regional lymph nodes (p=0.0007), increased angiogenesis (p=0.0085), and distant metastases (p=0.02) were the features potentially influencing prognosis. Multivariate analysis revealed independent prognostic value only in case of metastases in regional lymph nodes (p=0.013) and when distant metastases were present (p=0.021), but not when increased angiogenesis in primary colon adenocarcinoma was observed (p=0.078). In conclusion we can say that there is a close relationship between intensity of angiogenesis and overexpression of cathepsin B protein in cancer cells in resected colon adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004658

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  16 in total

1.  Targeted endoscopic imaging.

Authors:  Meng Li; Thomas D Wang
Journal:  Gastrointest Endosc Clin N Am       Date:  2009-04

2.  Histopathological analysis of cellular localization of cathepsins in abdominal aortic aneurysm wall.

Authors:  Fabian Lohoefer; Christian Reeps; Christina Lipp; Martina Rudelius; Alexander Zimmermann; Stefan Ockert; Hans-Henning Eckstein; Jaroslav Pelisek
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

3.  Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells.

Authors:  Eunok Im; Annapurna Venkatakrishnan; Andrius Kazlauskas
Journal:  Mol Biol Cell       Date:  2005-05-18       Impact factor: 4.138

4.  The clinical value of von Willebrand factor in colorectal carcinomas.

Authors:  Vera S Schellerer; Larissa Mueller-Bergh; Susanne Merkel; Robert Zimmermann; Dominik Weiss; Anne Schlabrakowski; Elisabeth Naschberger; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Am J Transl Res       Date:  2011-09-23       Impact factor: 4.060

5.  Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice.

Authors:  Weifang Yu; Jian Liu; Michael A Shi; Jianan Wang; Meixiang Xiang; Shiro Kitamoto; Bing Wang; Galina K Sukhova; George F Murphy; Gabriela Orasanu; Anders Grubb; Guo-Ping Shi
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

6.  Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB.

Authors:  Hendrick Soh; Natarajan Venkatesan; Mysore S Veena; Sandhiya Ravichandran; Alborz Zinabadi; Saroj K Basak; Kislay Parvatiyar; Meera Srivastava; Li-Jung Liang; David W Gjertson; Jorge Z Torres; Neda A Moatamed; Eri S Srivatsan
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

7.  RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Daniel Spomar; Christopher S Gondi; William C Olivero; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

8.  Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer.

Authors:  Mysore S Veena; Grant Lee; Daniel Keppler; Marc S Mendonca; J Leslie Redpath; Eric J Stanbridge; Sharon P Wilczynski; Eri S Srivatsan
Journal:  Genes Chromosomes Cancer       Date:  2008-09       Impact factor: 5.006

9.  VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.

Authors:  Sung-Hee Chang; Keizo Kanasaki; Vasilena Gocheva; Galia Blum; Jay Harper; Marsha A Moses; Shou-Ching Shih; Janice A Nagy; Johanna Joyce; Matthew Bogyo; Raghu Kalluri; Harold F Dvorak
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

10.  Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.

Authors:  Victoria Smith; Gregory J Wirth; Heinz-Herbert Fiebig; Angelika M Burger
Journal:  Cancer Genomics Proteomics       Date:  2008 Sep-Oct       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.